HANCOCK -- The Western Upper Peninsula Health Department (WUPHD) COVID-19 testing report of Friday, Apr. 10, 2020, shows an additional positive case in Gogebic County, bringing the Gogebic total to 4 positives, including one death. Houghton County testing continues to show one positive result, with zero positive tests for the other three counties -- Baraga, Keweenaw and Ontonagon.
WUPHD reports these totals for Apr. 10:
Referred for Testing: Baraga 29, Gogebic 73, Houghton 122, Keweenaw 12, Ontonagon 18, with a total of 254 for the 5 counties.
Tests Canceled*: Baraga 1, Gogebic 2, Houghton 11, Keweenaw 2, Ontonagon 2 -- a 5-county total of 18.
Positives: Baraga 0, Gogebic 4, Houghton 1, Keweenaw 0, Ontonagon 0 -- total of 5 for the counties.
Negatives: Baraga 21, Gogebic 55, Houghton 96, Keweenaw 8, Ontonagon 13 -- a 5-county total of 193.
Tests pending: Baraga 7, Gogebic 12, Houghton 14, Keweenaw 2, Ontonagon 3 -- total 38.
Deaths**: 1 death, Gogebic County.
* Canceled tests are those tests that a healthcare provider decided not to submit after other diagnostic procedures confirmed a different illness or a clinical decision was made to not test after a referral was already assigned to the system. Most canceled tests were done early on in the process. The process has improved and additional guidance is now available to all healthcare providers.
**Deaths are also included in the number of positive tests (they are not additional positives).
Showing posts with label COVID-19. Show all posts
Showing posts with label COVID-19. Show all posts
Friday, April 10, 2020
Responding to the COVID-19 Crisis: The Making of Vaccines
By Kelley Christensen, Michigan Tech Science and Technology Publications Writer
Posted April 2, 2020, on Michigan Tech News
Reprinted in part with permission
Caryn Heldt, director of the Michigan Tech Health Research Institute and the James and Lorna Mack Chair in Bioengineering, works with graduate student Ashish Saksule in her lab. Heldt and her collaborators are looking at both short-term and long-term solutions to more resilient vaccine manufacturing. (Photo courtesy Michigan Tech University)
HOUGHTON -- New purification methods may streamline the vaccine manufacturing process and make scaling up production easier.
A vaccine for COVID-19 is still being developed -- but when it is available, it will be manufactured in a standard three-step process. First, virus molecules for the vaccine are grown in cell cultures inside bioreactors. Second, the virus molecules are extracted from the cell cultures through a process called purification. Third, the vaccine is stabilized for shipping and storage. Researchers at Michigan Technological University are creating new processes to improve the purification step -- which often accounts for 50 percent to 70 percent of a vaccine’s manufacturing costs.
Current vaccine purification relies on ultracentrifugation, or spinning the cell cultures at high speed until their components separate. With this method, the only way to scale up production is by running 24 hours a day and buying more centrifuges. Caryn Heldt, director of the Michigan Tech Health Research Institute and the James and Lorna Mack Chair in Bioengineering, has studied ways to purify viruses without using ultracentrifugation for more than 15 years -- and her methods could be just as effective, faster and more efficient. ... Click here to read the rest of this article on Michigan Tech News.
Posted April 2, 2020, on Michigan Tech News
Reprinted in part with permission
HOUGHTON -- New purification methods may streamline the vaccine manufacturing process and make scaling up production easier.
A vaccine for COVID-19 is still being developed -- but when it is available, it will be manufactured in a standard three-step process. First, virus molecules for the vaccine are grown in cell cultures inside bioreactors. Second, the virus molecules are extracted from the cell cultures through a process called purification. Third, the vaccine is stabilized for shipping and storage. Researchers at Michigan Technological University are creating new processes to improve the purification step -- which often accounts for 50 percent to 70 percent of a vaccine’s manufacturing costs.
Current vaccine purification relies on ultracentrifugation, or spinning the cell cultures at high speed until their components separate. With this method, the only way to scale up production is by running 24 hours a day and buying more centrifuges. Caryn Heldt, director of the Michigan Tech Health Research Institute and the James and Lorna Mack Chair in Bioengineering, has studied ways to purify viruses without using ultracentrifugation for more than 15 years -- and her methods could be just as effective, faster and more efficient. ... Click here to read the rest of this article on Michigan Tech News.
Tuesday, March 03, 2020
Michigan Tech Travel Restriction expanded to Italy and Iran
By Scott Wendt, Michigan Tech Manager of Health and Safety, Environmental Health and Safety
Posted in Tech Today on March 3, 2020
HOUGHTON -- A community outbreak of the respiratory illness caused by a novel (new) coronavirus, COVID-19, has continued to spread to multiple countries. The U.S. Centers for Disease Control and Prevention (CDC) continues to closely monitor developments. At this time, the CDC has issued additional Level 3 Travel Health Notices for Italy and Iran. Currently, the CDC recommends travelers avoid all nonessential travel to the following countries: China, Iran, Italy, and South Korea.
Consistent with the CDC recommendation, Michigan Tech is issuing a University-wide travel restriction for Italy and Iran. Michigan Tech travel restrictions are also still in place for China and South Korea. The restriction applies to faculty, staff, and students. If you have essential travel scheduled to one of these countries, please contact the Office of General Counsel at 906-487-2318.
The University administration continues to monitor the situation for developments and will update the campus community as necessary. For Michigan-specific information on the coronavirus, please visit the Michigan Department of Health and Human Services webpage.
To get more information and view all updates from Michigan Tech, visit: mtu.edu/covid-19
Posted in Tech Today on March 3, 2020
HOUGHTON -- A community outbreak of the respiratory illness caused by a novel (new) coronavirus, COVID-19, has continued to spread to multiple countries. The U.S. Centers for Disease Control and Prevention (CDC) continues to closely monitor developments. At this time, the CDC has issued additional Level 3 Travel Health Notices for Italy and Iran. Currently, the CDC recommends travelers avoid all nonessential travel to the following countries: China, Iran, Italy, and South Korea.
Consistent with the CDC recommendation, Michigan Tech is issuing a University-wide travel restriction for Italy and Iran. Michigan Tech travel restrictions are also still in place for China and South Korea. The restriction applies to faculty, staff, and students. If you have essential travel scheduled to one of these countries, please contact the Office of General Counsel at 906-487-2318.
The University administration continues to monitor the situation for developments and will update the campus community as necessary. For Michigan-specific information on the coronavirus, please visit the Michigan Department of Health and Human Services webpage.
To get more information and view all updates from Michigan Tech, visit: mtu.edu/covid-19
Subscribe to:
Posts (Atom)
